Safety of endoscopic retrograde cholangiopancreatography in patients 80 years of age and older

Basit Öğe Kaydı
dc.contributor.authorBehlül B.
dc.contributor.authorAyfer S.
dc.contributor.authorSezgin V.
dc.contributor.authorAltay K.
dc.contributor.authorMustafa Ç.
dc.contributor.authorCem Ç.
dc.contributor.authorBilge Ö.
dc.contributor.authorFatih A.
dc.contributor.authorEmrah A.
dc.contributor.authorZafer B.
dc.contributor.authorKadir A.
dc.contributor.authorBelkis Ü.
dc.date.accessioned2019-10-26T21:32:50Z
dc.date.available2019-10-26T21:32:50Z
dc.date.issued2014
dc.departmentEge Üniversitesien_US
dc.description.abstractIntroduction: Endoscopic retrograde cholangiopancreatography (ERCP) is used in the diagnosis and therapy of biliary tract diseases. The ERCP is an invasive procedure that does not increase complications in the elderly. Few studies have assessed the safety of ERCP in the elderly. Life expectancy is rising, which causes an increasing demand for ERCP in the elderly. Aim: To show that therapeutic ERCP is safe and we compared the level of complications among the elderly (> 80 years of age) and the level among a younger group (< 65 years of age). Material and methods: The study was designed retrospectively. The details of all patients 80 years of age and older undergoing ERCP were analysed. One hundred and fifty patients were included in each of the groups: > 80 years of age, older group A; and < 65 years of age, younger group B. Results: In group A, 4 cases (2.7%) of bleeding (all mild) was observed, and perforation was not observed. The ERCP-related mild pancreatitis was observed in 7 patients (4.6%). There were no cases of mortality during procedures of ERCP in group A. In group B 6 bleeding cases (4%) (all mild) were observed. Perforation was not observed in group B. ERCP-related mild pancreatitis occurred in 11 patients (7.3%). There were no cases of mortality during procedures of ERCP in group B. Our study showed that ERCP is a safe and effective procedure in elderly patients. Conclusions: Outcomes of ERCP for diagnostic and therapeutic success, and complication rates, are similar to those in younger patients. The ERCP is effective and safe in the elderly. © 2014 Termedia Sp. z o.o. All rights reserved.en_US
dc.identifier.doi10.5114/pg.2014.45105
dc.identifier.endpage231en_US
dc.identifier.issn1895-5770
dc.identifier.issn1895-5770en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage227en_US
dc.identifier.urihttps://doi.org/10.5114/pg.2014.45105
dc.identifier.urihttps://hdl.handle.net/11454/17782
dc.identifier.volume9en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltd.en_US
dc.relation.ispartofPrzeglad Gastroenterologicznyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectElderlyen_US
dc.subjectEndoscopic retrograde cholangiopancreatographyen_US
dc.subjectIndicationsen_US
dc.subjectSafetyen_US
dc.titleSafety of endoscopic retrograde cholangiopancreatography in patients 80 years of age and olderen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu